Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanospear Technology Developed for Directed Gene Therapy

By LabMedica International staff writers
Posted on 29 Mar 2018
A novel delivery system for macromolecular compounds such as genes depends on nanoscale splinter-like structures that have been termed "nanopsears."

Currently, gene therapy relies on modified viruses, external electrical fields, or harsh chemicals to penetrate cell membranes and deliver genes to target cells. More...
Each of these methods has its own shortcomings; it can be costly, inefficient, or cause undesirable stress and toxicity to cells.

In an effort to circumvent these shortcomings, investigators at the University of California, Los Angeles (USA) developed an efficient nonviral platform for high-throughput and subcellular precision-targeted intracellular delivery of nucleic acids in cell culture based on magnetic nanospears. The biodegradable nanospears were composed of silicon, nickel, and gold. They could be mass-produced inexpensively and efficiently, and, due to their size, could deliver genetic information with minimal impact on cell viability and metabolism.

A magnet was used to direct the mechanical motion of a single nanospear, enabling precise control of position and three-dimensional rotation. The nanospears were further functionalized with enhanced green fluorescent protein (eGFP)-expression plasmids via a layer-by-layer approach before release from the underlying silicon substrate. Plasmid functionalized nanospears were guided magnetically to approach target adherent U87 glioblastoma cells, penetrating the cell membrane to enable intracellular delivery of the plasmid cargo.

Results published in the March 14, 2018, online edition of the journal ACS Nano revealed that after 24 hours, the target cell expressed green fluorescence indicating successful transfection. Nanospear-mediated transfection was readily scalable for the simultaneous manipulation of multiple cells using a rotating magnet. Cell viability was greater than 90% and transfection rates exceeding 80% were achieved, which outperformed conventional nonviral intracellular methods.

"We knew how to make nanostructures of different shapes in massive numbers using simple fabrication strategies," said senior author Dr. Paul Weiss, professor of chemistry, biochemistry, materials science, and engineering at the University of California, Los Angeles. "Once we had that in hand, we realized we could make precise structures that would be of value in gene therapies. One of the amazing things about working at UCLA is that for each of the targeted diseases, we collaborate with leading clinicians who already have gene therapies in development. They have the gene-editing cargo, model cells, animal models, and patient cells in place so we are able to optimize our nanosystems on methods that are on the pathway to the clinic."

Related Links:
University of California, Los Angeles


New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
Sample Transportation System
Tempus1800 Necto
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Pathology

view channel
Image: The new system allows surgeons to identify genotyping of brain tumors and determine optimal resection margins during surgery (Photo courtesy of Nagoya University)

New Technique Detects Genetic Mutations in Brain Tumors During Surgery within 25 Minutes

Determining the genetic profile of brain tumors during surgery is crucial for improving patient outcomes, but conventional analysis methods can take up to two days, delaying critical decisions.... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.